Select for export Precision Functional Brain Mapping to Understand the Mechanisms of Psilocybin Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-10-30 Washington University School of Medicine ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin Brain ImagingMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-025-03654-3 PubMed 41173871 Copy citation Copy BibTeX Unknown journal 2025-10-30 d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM Europe PMC Published psilocybin DepressionAnxietyBrain Imaging Systematic Review More
Select for export A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-10-29 Ohio State University ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionAnxietyNeuroplasticity Clinical Trial More
Select for export Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticity Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopha.2025.118720 PubMed 41172953 Copy citation Copy BibTeX Biomedicine & Pharmacotherapy 2025-10-29 Rubén García-Cabrerizo, Itziar Beruete-Fresnillo, Pedro Bergas-Cladera, M. Julia García-Fuster OpenAlex Published psilocybin DepressionNeuroplasticityNeurogenesis Observational Study More
Select for export A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)? Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-10-28 Anna Rose Childress, Ph.D. ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAddictionOCD Clinical Trial More
Select for export Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence Abstract available at the source but not redistributed here. Read at source. Details DOI 10.61373/pp025i.0044 Copy citation Copy BibTeX Psychedelics. 2025-10-27 James J Gattuso, Bilgenur Bezcioglu, Carey Wilson, Kato Havaux, Anthony J. Hannan, Thibault Renoir OpenAlex Published psilocybinpsilocin DepressionAnxietyOCD Randomized Controlled Trial More
Select for export Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s40814-025-01706-5 PubMed 41152967 Copy citation Copy BibTeX Pilot and Feasibility Studies 2025-10-27 Candice Richardson, Cindy Chan, Emily Macgregor, Crystal Hare, Breffni Hannon, SarahRose Black OpenAlex Published psilocybin Chronic PainClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Provider perspectives on challenges in treatment during psychedelic therapy No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-025-06907-7 PubMed 41139739 Copy citation Copy BibTeX Psychopharmacology 2025-10-26 David A. Bender, Sandeep M. Nayak, Joshua S. Siegel, David J. Hellerstein, Barış Erçal, Eric J. Lenze OpenAlex Published psilocybin Chronic PainClinical TrialToxicity Clinical Trial More
Select for export A Systematic Review and Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Use Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/healthcare13212668 PubMed 41228035 Copy citation Copy BibTeX Unknown journal 2025-10-22 Keighley EE, Abo Hamza E, Bedewy DA, Nalla S, Moustafa AA. Europe PMC Published psilocybin AddictionClinical TrialMeta-Analysis Meta-Analysis More
Select for export Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pnpbp.2025.111541 PubMed 41138900 Copy citation Copy BibTeX Unknown journal 2025-10-22 Bukovsky D, Amaev A, Song J, Kyte S, Carmona-Torres E, Ueno F Europe PMC Published psilocybin DepressionAnxietyAddiction Systematic Review More
Select for export Psychedelics and time: Exploring altered temporal perception and its implications for consciousness, neuroscience, and therapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.61373/pp025p.0041 Copy citation Copy BibTeX Psychedelics. 2025-10-20 Pu Jiang, Cong Lin, Xiaohui Wang OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older Adults Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-10-20 University of California, Berkeley ClinicalTrials.gov CLINICAL TRIAL psilocybin NeuroplasticityBrain ImagingAging Observational Study More
Select for export Is there more to magic mushrooms than psilocybin? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/cen-10322-feature2 Copy citation Copy BibTeX C&EN Global Enterprise 2025-10-19 special to C EN Mara Johnson-Groh OpenAlex Published psilocybinpsilocin DepressionAddictionOCD Clinical Trial More
Select for export The THRIVE Model of Psychedelic Integration: A Holistic Framework Bridging Indigenous Knowledge and Evidence-Based Practice No abstract availability was recorded for this entry. Details DOI 10.1007/s40501-025-00368-7 Copy citation Copy BibTeX Current Treatment Options in Psychiatry 2025-10-19 Ashvind N. Singh, Glauber Loures de Assis OpenAlex Published psilocybin General Other More
Select for export Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trials No abstract availability was recorded for this entry. Details DOI 10.1016/j.neuropharm.2025.110722 PubMed 41110634 Copy citation Copy BibTeX Neuropharmacology 2025-10-16 Luisa Prochazkova, Josephine Marschall, Dominique P. Lippelt, Neil R Schon, Martin Kuchař, Bernhard Hommel OpenAlex Published psilocybin Chronic PainMicrodosingClinical Trial Clinical Trial More
Select for export Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activation Abstract available at the source but not redistributed here. Read at source. Details DOI 10.17615/ce6e-4888 Copy citation Copy BibTeX UNC Libraries 2025-10-15 Gabriele M. König, Li-Ming Hsu, Yi-Ting Chiu, Gavin P. Schmitz, Martin MacKinnon, Yen-Yu I. Shih OpenAlex Published psilocybinpsilocin NeuroplasticityBrain ImagingMechanism of Action Other More
Select for export Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20451253251384513 PubMed 41122434 Copy citation Copy BibTeX Unknown journal 2025-10-15 Wong S, Jones BDM, Thiyagarajah MT, Sabbah SG, Thompson C, Solmi M Europe PMC Published psilocybin DepressionBrain ImagingMechanism of Action Systematic Review More
Select for export Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811251382147 PubMed 41099474 Copy citation Copy BibTeX Journal of Psychopharmacology 2025-10-15 David J. Heal, Jane Gosden, Sharon L. Smith OpenAlex Published psilocybin Mechanism of ActionReceptor PharmacologyClinical Trial Clinical Trial More
Select for export A novel psychedelic 5-HT2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811251378512 PubMed 41099491 Copy citation Copy BibTeX Journal of Psychopharmacology 2025-10-15 Gerard J. Marek, Soma Makai-Bölöni, Daniel Umbricht, Edward P. Christian, Jason Winters, Dino Dvořák OpenAlex Published psilocybin DepressionBrain ImagingPharmacology Randomized Controlled Trial More
Select for export Structure-GuidedDesign of Novel 5-HT2A Partial Agonists as PsychedelicAnalogues with Antidepressant Effects Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acs.jmedchem.5c02045.s001 Copy citation Copy BibTeX Figshare 2025-10-14 Rongyan Li (11403789), Haohan Yan (22432650), Yujin Chen (1412254), Yangyang Liu (807797), Lingjie Tang (9276407), Jing Yu (81085) OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Animal Study More
